ACEA Biosciences logo

ACEA Biosciences

Evelopment and commercialization of high performance cell analysis platforms for life science research

55 employees · est. 2002 · San Diego, United States

VS
Samplix logo

Samplix

Reveal cell function with single-cell resolution.

35 employees · est. 2013 · Denmark

ACEA Biosciences is the older company (2002 vs 2013); ACEA Biosciences is the larger of the two.

Side-by-Side Comparison

ACEA Biosciences Samplix
Founded
2002 older 2013
Headquarters
San Diego, United States Denmark
Employees
55 larger 35
Industry
Analytics, Biotechnology, Autonomous and Sensor Tech Biotechnology, Information Technology
Funding Stage
Unknown Series Unknown
Total Funding
$321.00M $12.67M
Funding Rounds
5 3
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Cell Analysis Platforms, Real-Time Cell Analysis, Flow Cytometry, Preclinical Drug Discovery, Toxicology, Safety Pharmacology, Oncology Drug Discovery, Biosensor Technology, Cell-Based Assays, Cardiotoxicity Research, Immunotherapy, Cancer Research, Drug Screening, Infectious Disease Research, Stem Cell Research Single-cell Analysis, Immunotherapy Research, Double Emulsion Technology, Flow Cytometry, Cell Sorting, Xdrop Technology, Living Cells Encapsulation, Reactive Molecules, Microenvironment, Flow Cytometry And Sorting, Engineered Cell Therapy Research, Protein Engineering, Synthetic Biology Workflows, Cell Interaction, Cell Secretion
Website
aceabio.com samplix.com
ACEA Biosciences logo

About ACEA Biosciences

ACEA Biosciences, now part of Agilent Technologies, stands at the forefront of the biotech industry with its high-performance cell analysis platforms. Since its founding in 2002, this United States-based company has innovatively contributed to Analytics, Biotechnology, and Autonomous and Sensor Tech...

Samplix logo

About Samplix

Samplix is a Denmark-based biotechnology startup founded in 2013 with a focus on single-cell analysis in immunotherapy research. The company's flagship product, Xdrop, utilizes double emulsion technology to encapsulate living cells and reactive molecules in stable droplets, enabling rapid cell-cell...

We will tell you when either one moves

BounceWatch watches ACEA Biosciences and Samplix for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at ACEA Biosciences and Samplix — by email.

Frequently Asked Questions

ACEA Biosciences — Evelopment and commercialization of high performance cell analysis platforms for life science research. Samplix — Reveal cell function with single-cell resolution.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
ACEA Biosciences has raised $321.00M while Samplix has raised $12.67M.
ACEA Biosciences and Samplix operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare ACEA Biosciences with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at ACEA Biosciences on 2 Apr 2026, and Samplix on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy